GlassScriptPhysician profile
Katarzyna Perlman
NPI 1568431369
$1,913.13
in general payments reported to CMS, 2019-2025
15 companies · $447 in 2025
The $447 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.34 · 2020: $116 · 2021: $275 · 2022: $303 · 2023: $434 · 2024: $280 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $448.06 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Biogen, INC. | $197.63 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $194.23 | 2020-2025 | Slynd |
| Abbvie INC. | $188.07 | 2020-2022 | |
| Daiichi Sankyo INC. | $172.02 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $145.21 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $120.95 | 2023-2025 | Myfembree |
| Aspira Women'S Health INC | $104.65 | 2021-2022 | |
| Therapeuticsmd, INC. | $99.79 | 2019-2022 | |
| Organon LLC | $87.62 | 2022-2025 | Jada System |
| Evofem Biosciences, INC. | $62.45 | 2021-2025 | Solosec, Phexx, Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $49.29 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $16.12 | 2025 | |
| Merck Sharp & Dohme LLC | $13.96 | 2020 | |
| Agile Therapeutics, INC. | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katarzyna Perlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.